Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Yong In, MD"
11
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT06557213
Not Yet Recruiting
a Cohort Study (Gut Microbiota and HCC)
Nanjing Xiershou Biotechnology Co., Ltd
ClinicalTrials.gov
NCT06557213
Not Yet Recruiting
-
a Cohort Study (Gut Microbiota and HCC)
Nanjing Xiershou Biotechn...
NCT06563934
Not Yet Recruiting
Phase 2
Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs)
Nanjing Xiershou Biotechnology Co., Ltd
ClinicalTrials.gov
NCT06563934
Not Yet Recruiting
Phase 2
Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs)
Nanjing Xiershou Biotechn...
NCT06563947
Recruiting
Phase 2
Oral Fecal Microbiota Transplantation in Advanced Hepatocellular Carcinoma After Progression on ICI-TKI Therapy
Nanjing Xiershou Biotechnology Co., Ltd
ClinicalTrials.gov
NCT06563947
Recruiting
Phase 2
Oral Fecal Microbiota Transplantation in Advanced Hepatocellular Carcinoma After...
Nanjing Xiershou Biotechn...
NCT07204262
Completed
Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma
Xu Yong, MD
ClinicalTrials.gov
NCT07204262
Completed
-
Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma
Xu Yong, MD
NCT03086681
Completed
Phase 2
Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma
Yong Zhang,MD
ClinicalTrials.gov
NCT03086681
Completed
Phase 2
Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervica...
Yong Zhang,MD
NCT04011020
Active Not Recruiting
Phase 3
Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
Yong Zhao, MD, PhD
ClinicalTrials.gov
NCT04011020
Active Not Recruiting
Phase 3
Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
Yong Zhao, MD, PhD
NCT05588219
Unknown
Phase 2
Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Yong Zhang,MD
ClinicalTrials.gov
NCT05588219
Unknown
Phase 2
Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cer...
Yong Zhang,MD
NCT06017583
Unknown
Phase 3
Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer
Yong Zhang,MD
ClinicalTrials.gov
NCT06017583
Unknown
Phase 3
Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Trea...
Yong Zhang,MD
NCT06329154
Unknown
Not Applicable
Clinical Study On Extracorporeal Shock Wave Therapy For Rotator Cuff Injuries
Yong Liu, MD
ClinicalTrials.gov
NCT06329154
Unknown
Not Applicable
Clinical Study On Extracorporeal Shock Wave Therapy For Rotator Cuff Injuries
Yong Liu, MD
NCT07595718
Recruiting
AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases
Jae Yong Jeon, MD
ClinicalTrials.gov
NCT07595718
Recruiting
-
AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases
Jae Yong Jeon, MD
NCT03192670
Unknown
Not Applicable
A Study of Low-level Light Therapy Using Photo-activated Modulation Ameliorates Cognitive Deficits
Samsung Medical Center
ClinicalTrials.gov
NCT03192670
Unknown
Not Applicable
A Study of Low-level Light Therapy Using Photo-activated Modulation Ameliorates...
Samsung Medical Center
Result Breakdown
Status
Unknown
4 (36%)
Not yet recruiting
2 (18%)
Recruiting
2 (18%)
Completed
2 (18%)
Active, not recruiting
1 (9%)
Phase
Phase 2
4 (36%)
Not Specified
3 (27%)
Phase 3
2 (18%)
not_applicable
2 (18%)
Top Conditions
Liver Cancer
3 (27%)
Advanced Hepatocellular Carcinoma
1 (9%)
Cervical Carcinoma
1 (9%)
Show 7 more
Top Sponsors
Xu Yong, MD
4 (36%)
Nanjing Xiershou Biotechnology Co., Ltd
3 (27%)
Yong Zhang,MD
3 (27%)
Show 5 more
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease